Literature DB >> 12050922

[Osteoporosis: prevention, diagnosis and therapy].

Alexandra Hennemann1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12050922

Source DB:  PubMed          Journal:  Med Monatsschr Pharm        ISSN： 0342-9601


× No keyword cloud information.
  4 in total

1.  Periostin-modified bone marrow mesenchymal stem cells from osteoporotic rats promote alveolar bone regeneration.

Authors:  Doudou Li; Weiwei Zhou; Meng Cao
Journal:  J Mol Histol       Date:  2019-09-14       Impact factor: 2.611

2.  Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway.

Authors:  Xuenan Liu; Zheng Li; Hao Liu; Yuan Zhu; Dandan Xia; Siyi Wang; Ranli Gu; Weiliang Wu; Ping Zhang; Yunsong Liu; Yongsheng Zhou
Journal:  Stem Cell Res Ther       Date:  2019-07-19       Impact factor: 6.832

3.  12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women.

Authors:  Meng Kong; Chuanli Zhou; Kai Zhu; Yiran Zhang; Mengxiong Song; Hao Zhang; Qihao Tu; Xuexiao Ma
Journal:  Clin Interv Aging       Date:  2019-10-01       Impact factor: 4.458

4.  A Mendelian Randomization Analysis to Expose the Causal Effect of IL-18 on Osteoporosis Based on Genome-Wide Association Study Data.

Authors:  Ni Kou; Wenyang Zhou; Yuzhu He; Xiaoxia Ying; Songling Chai; Tao Fei; Wenqi Fu; Jiaqian Huang; Huiying Liu
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.